Abstract:Mitochondrial dysfunction has long been implicated to have a causative role in organismal aging. A mitochondrial molecule, nucleotide-binding domain and leucine-rich-repeat-containing protein X1 (NLRX1), represents the only NLR family member that targets this cellular location, implying that NLRX1 probably establishes a fundamental link between mitochondrial functions and cellular physiology. However, the significance of NLRX1 function in cellular senescence, a key conceptual constituent in aging biology, is yet to be defined. Here, we demonstrate that molecular hallmarks involved in aging biology including NAD+ decline, and activation of mTOR, p53, and p16INK4A are significantly enhanced in NLRX1 deficiency in vitro. Mechanistic studies of replicative cellular senescence in the presence or absence of NLRX1 in vitro reveal that NLRX1-deficient fibroblasts fail to maintain optimal NAD+/NADH ratio, which instigates the decline of SIRT1 and the activation of mTOR, p16INK4A, and p53, leading to the increase in senescence-associated beta-galactosidase (SA-β-gal)-positive cells. Importantly, the enhanced cellular senescence response in NLRX1 deficiency is significantly attenuated by pharmacological inhibition of mTOR signaling in vitro. Finally, our in vivo murine studies reveal that NLRX1 decreases with age in murine lungs and NLRX1 deficiency in vivo accelerates pulmonary functional and structural changes that recapitulate the findings observed in human aging lungs. In conclusion, the current study provides evidence for NLRX1 as a crucial regulator of cellular senescence and in vivo lung aging.

CRISPR screening uncovers nucleolar RPL22 as a heterochromatin destabilizer and senescence driver

METTL14 Regulates Intestine Cellular Senescence Through M6a Modification of Lamin B Receptor

A non-canonical role for a small nucleolar RNA in ribosome biogenesis and senescence

A large-scale CRISPR screen and identification of essential genes in cellular senescence bypass.

CRL2APPBP2-mediated TSPYL2 degradation counteracts human mesenchymal stem cell senescence

Nucleolar stress caused by arginine-rich peptides triggers a ribosomopathy and accelerates aging in mice

CRL2 APPBP2 -Mediated TSPYL2 Degradation Counteracts Human Mesenchymal Stem Cell Senescence

Identification of the Lncrna, AK156230, As a Novel Regulator of Cellular Senescence in Mouse Embryonic Fibroblasts.

RNaseH2A downregulation drives inflammatory gene expression via genomic DNA fragmentation in senescent and cancer cells

Genome-wide CRISPR activation screening in senescent cells reveals SOX5 as a driver and therapeutic target of rejuvenation

Disruption of nucleocytoplasmic trafficking as a cellular senescence driver

Divergent regulation of long non-coding RNAs H19 and PURPL affects cell senescence in human dermal fibroblasts

Alternative polyadenylation dependent function of splicing factor SRSF3 contributes to cellular senescence.

Mtorc1-Rps15 Axis Contributes to the Mechanisms Underlying Global Translation Reduction During Senescence of Mouse Embryonic Fibroblasts

Mitochondria-to-nucleus retrograde signaling drives formation of cytoplasmic chromatin and inflammation in senescence

Nucleotide‐binding domain and leucine‐rich‐repeat‐containing protein X1 deficiency induces nicotinamide adenine dinucleotide decline, mechanistic target of rapamycin activation, and cellular senescence and accelerates aging lung‐like changes

Prevalent Intron Retention Fine‐tunes Gene Expression and Contributes to Cellular Senescence

A senescence-specific lncRNA controls metabolic rewiring of senescent cells

Hnrnp A1 Antagonizes Cellular Senescence and Senescence‐associated Secretory Phenotype Via Regulation of SIRT1 Mrna Stability

Global lengthening of 3ʹ untranslated regions of mRNAs by alternative cleavage and polyadenylation in cellular senescence

3′ UTR lengthening as a novel mechanism in regulating cellular senescence